Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Lidds AB
LIDDSCurrent price
0.14 SEK
+0.035 SEK (+35.00%)
Last closed
0.1 SEK
Company
www.liddspharma.com
ISIN
SE0001958612
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
21 886 730 SEK
Yield for 12 month
-23.30 %
1Y
3Y
5Y
10Y
15Y
LIDDS
LIDDS AB (publ), a drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden. The company's oncology pipeline in clinical development includes Liproca Depot, a NanoZolid-formulated 2-hydroxyltutamide (2-HOF), which is an anti-androgen drug that binds and blocks androgen receptors; Nanodotax, a NanoZolid-formulated docetaxel, which is a chemotherapy medication that is approved for various oncological conditions, such as breast cancer, head and neck cancer, and prostate cancer; and Nanoimod, a NanoZolid-formulated agatolimod, which is a toll-like receptor 9 (TLR9) agonist. The company was founded in 2003 and is based in Uppsala, Sweden. Address: Virdings allé 32B, Uppsala, Sweden, 754 50
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
46.24 SEKP/E ratio
–Dividend Yield
–Current Year
-110 265 SEK
Last Year
+1 892 554 SEK
Current Quarter
–
Last Quarter
+23 055 SEK
Current Year
-12 953 163 SEK
Last Year
-36 708 305 SEK
Current Quarter
-5 011 SEK
Last Quarter
-578 389 SEK
Key Figures LIDDS
1 year
3 years
5 years
10 years
EBITDA
-25 698 818 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-61.89 %
PEG Ratio
–
Return On Equity TTM
-114.25 %
Wall Street Target Price
46.24 SEK
Revenue TTM
17 041 SEK
Book Value
0.057 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
175.8 %
Dividend Yield
–
Gross Profit TTM
-20 871 205 SEK
Earnings per share
-0.37 SEK
Diluted Eps TTM
-0.37 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LIDDS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LIDDS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
326:303
Payout Ratio
–
Last Split Date
17.01.2023
Dividend Date
–
Stock Valuation LIDDS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8.9624
Price Sales TTM
1284.3577
Enterprise Value EBITDA
-1.085
Price Book MRQ
2.8275
Financials LIDDS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LIDDS
For 52 weeks
0.096 SEK
0.37 SEK
50 Day MA
0.12 SEK
Shares Short Prior Month
–
200 Day MA
0.15 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart